Terremoto raises $108M to pursue development of drugs targeting AKT
The California biotech has one therapy in Phase 1 testing and expects another to advance to the clinic later this year.
Read the full article on the original site.
Read Full Article
The California biotech has one therapy in Phase 1 testing and expects another to advance to the clinic later this year.
Read the full article on the original site.
Read Full Article